Akari Therapeutics Plc Annual Interest Expense in USD from 2014 to 2017

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Akari Therapeutics Plc quarterly/annual Interest Expense history and growth rate from 2014 to 2017.
  • Akari Therapeutics Plc Interest Expense for the quarter ending June 30, 2024 was $51K.
  • Akari Therapeutics Plc annual Interest Expense for 2017 was $0.000.
  • Akari Therapeutics Plc annual Interest Expense for 2016 was $0.000, a 100% decline from 2015.
  • Akari Therapeutics Plc annual Interest Expense for 2015 was $3.05K, a 43.8% decline from 2014.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 20-F 2018-07-18
2016 $0 -$3.05K -100% Jan 1, 2016 Dec 31, 2016 20-F 2018-07-18
2015 $3.05K -$2.38K -43.8% Jan 1, 2015 Dec 31, 2015 20-F 2018-07-18
2014 $5.44K Jan 1, 2014 Dec 31, 2014 20-F 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.